Companion drugs for amphotericin B in cryptococcal meningitis: flucytosine, fluconazole, or...Nothing?

Editorial

John Bennett. Clin Infect Dis. 2012.

. 2012 Jan 1;54(1):129-30.

doi: 10.1093/cid/cir758. Epub 2011 Nov 3.

No abstract available

Comment on

Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
Loyse A, Wilson D, Meintjes G, Jarvis JN, Bicanic T, Bishop L, Rebe K, Williams A, Jaffar S, Bekker LG, Wood R, Harrison TS. Loyse A, et al. Clin Infect Dis. 2012 Jan 1;54(1):121-8. doi: 10.1093/cid/cir745. Epub 2011 Nov 3. Clin Infect Dis. 2012. PMID: 22052885 Clinical Trial.

1. Loyse A, Wilson D, Meintjes G, et al. Comparison of the early fungicidal activity of high dose fluconazole, voriconazole, and flucytosine, as second drug given in combination with amphotericin B, for the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis. 2011;54:121–8. - PubMed
1. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291–322. - PMC - PubMed
1. van der Horst CM, Saag MS, Cloud GA, et al. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med. 1997;337:15–21. - PubMed
1. Saag MS, Cloud GA, Graybill JR, et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis. 1999;28:291–6. - PubMed
1. Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomized trial. Lancet. 2004;363:1764–7. - PubMed